{"id":13069,"date":"2024-08-23T05:45:30","date_gmt":"2024-08-23T03:45:30","guid":{"rendered":"https:\/\/valintermed.com\/?p=13069"},"modified":"2024-08-23T05:45:30","modified_gmt":"2024-08-23T03:45:30","slug":"spinotserebellyarnaya-ataksiya-tip-3","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/spinal-cord-injury-tip-3\/","title":{"rendered":"Spinocerebellar ataxia type 3"},"content":{"rendered":"
<\/div>\n

Spinocerebellar ataxia type 3 (CA3) is a genetically determined neurological disorder belonging to the group of spinocerebellar ataxias, characterized by progressive deterioration of motor coordination, balance, and specific neurological symptoms. This disease is associated with degeneration of cells located in the spinal cord and cerebellum, which leads to impaired motor functions. The main clinical manifestations of CA3 include ataxia, dyspraxia, speech impairment, and possible neurological symptoms such as paresthesia and muscle relaxation. These manifestations usually begin to develop in middle age, and over time, there is a progression of symptoms, which significantly worsens the quality of life of patients.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n